PEEK 임플란트 시장 규모, 점유율, 동향 분석 리포트 : 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

PEEK Implants Market Size, Share & Trends Analysis Report By Application (Spinal Implants, Orthopedic Implants, Dental Implants), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,828,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,311,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 13,279,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

PEEK 임플란트 시장의 성장과 동향 :

Grand View Research, Inc의 최신 리포트에 따르면 세계의 PEEK 임플란트 시장 규모는 2024-2030년에 7.9%의 CAGR을 기록하며, 2030년에는 15억 2,040만 달러에 달할 것으로 예측되고 있습니다.

폴리에테르에테르케톤(PEEK) 임플란트는 내식성, 저중량, 생체 적합성 등의 장점으로 인해 향후 수년간 널리 보급 될 것으로 예상되며, PEEK 임플란트는 생체 적합성이 뛰어나고 신체에 대한 내성이 높아 부작용과 거부 반응의 위험을 줄일 수 있습니다. 이러한 특성으로 인해 이 임플란트는 정형외과, 척추, 치과 수술 등 다양한 의료 분야에 적합합니다.

전체적으로 제품 수요 증가는 생체 적합성, 기계적 특성, 방사선 투과성, 범용성 등의 장점을 가진 혁신적인 생체 재료에 대한 지속적인 추세를 반영하고 있습니다. PEEK 폴리머는 의료진과 환자들이 제품의 장점을 점점 더 많이 인식함에 따라 다양한 의료 전문 분야에서 채택이 계속 확대될 것으로 예상되며, PEEK 폴리머는 방사선 투과성을 통해 의료진이 임플란트를 통해 뼈의 유합을 확인할 수 있으므로 주로 척추 임플란트에 사용됩니다. PEEK의 주요 제조업체들이 집중하고 있는 주요 분야 중 하나가 척추 시장입니다. 신제품 출시와 기업 제휴 및 인수합병 증가가 시장 성장을 촉진하고 있습니다.

예를 들어 2022년 독일 뮌헨에 위치한 맞춤형 의료용 적층 가공 솔루션 개발 업체인 Kumovis GmbH는 3D Systems Corporation에 인수되었습니다. PEEK와 같은 고성능 의료용 폴리머를 정밀하게 인쇄할 수 있도록 개발된 독자적인 압출 공정을 기반으로 합니다. 또한 PEEK 임플란트가 의료 전문가와 규제기관에 의해 수용되고 있는 것도 시장 확대의 주요 요인으로 작용하고 있으며, 2023년 지역별 시장 규모는 북미가 41.5%로 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 북미 시장 확대의 배경에는 시장 진출기업의 존재, 정형외과 질환 증가, 정부의 신제품 권장 등이 있습니다.

PEEK 임플란트 시장 보고서 하이라이트

• 시장 규모는 2023년 9억 630만 달러로 추정되며, 2024년에는 9억 6,490만 달러에 달할 것으로 예상됩니다.
• 척추 임플란트 용도는 2023년 36.9% 이상의 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.
• 이 높은 점유율은 척추 질환 증가에 기인합니다.
• 병원 및 클리닉 최종 용도 부문은 2023년 약 64.1%의 점유율로 시장을 장악했습니다.
• 병원은 1차 의료 서비스 프로바이더로서 지역내 개인에게 다양한 의료 서비스를 제공하고 있으며, 이는 부문 성장의 주요 요인으로 작용하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 PEEK 임플란트 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 촉진요인 분석
  • 시장 억제요인 분석
• PEEK 임플란트 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTEL 분석

제4장 PEEK 임플란트 시장 : 용도 추정·동향 분석

• PEEK 임플란트 시장 : 용도 대시보드
• PEEK 임플란트 시장 : 용도 변동 분석
• PEEK 임플란트 시장 규모와 예측·동향 분석, 용도별, 2018-2030년
• 척추 임플란트
• 정형외과용 임플란트
• 치과 임플란트
• 두개악안면 임플란트
• 기타

제5장 PEEK 임플란트 시장 : 최종 용도 추정·동향 분석

• PEEK 임플란트 시장 : 최종 용도 대시보드
• PEEK 임플란트 시장 : 최종 용도 변동 분석
• PEEK 임플란트 시장 규모와 예측·동향 분석, 최종 용도별, 2018-2030년
• 병원·클리닉
• 외래 수술 센터
• 기타

제6장 PEEK 임플란트 시장 : 지역 추정·동향 분석

• 지역의 대시보드
• 시장 규모와 예측·동향 분석, 2018-2030년
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제7장 경쟁 구도

• 주요 시장 참여 기업에 의한 최근 동향과 영향 분석
• 기업/경쟁 분류
• 벤더 구도
  • Invibio
  • Johnson &Johnson MedTech
  • Evonik
  • Solvay
  • In2Bones Global, Inc
  • HAPPE Spine
  • NuVasive, Inc.
  • Dental Technology Services
  • 3D Systems, Inc.
  • INNOVASIS
  • SINTX Technologies, Inc.
  • Quick Implants NZ Limited.

KSA

영문 목차

영문목차

PEEK Implants Market Growth & Trends:

The global PEEK implants market size is anticipated to reach USD 1,520.4 million by 2030, registering a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Polyetheretherketone (PEEK) implants are expected to become popular in the years to come due to their advantages, including their resistance to corrosion, low weight, and biocompatibility. In addition, there is a greater need for PEEK implants due to the trend of minimally invasive surgical techniques.PEEK implants are biocompatible, meaning they are well-tolerated by the body, reducing the risk of adverse reactions or rejection. This property makes these implants suitable for a wide range of medical applications, including orthopedic, spinal, and dental surgeries.

Overall, the rising product demand reflects the ongoing trend toward innovative biomaterials that offer advantages in terms of biocompatibility, mechanical properties, radiolucency, and versatility. As healthcare providers and patients increasingly recognize the product benefits, their adoption is expected to continue to grow across a wide range of medical specialties. PEEK polymers are mostly used in spinal implants as their radiolucency enables medical personnel to see the bone fusion through the implant. One of the main areas of concentration for top PEEK manufacturers is the spine market. Increased number of new product launches and company collaborations/acquisitions have been fueling market growth.

For instance, in 2022, Kumovis GmbH, a developer of additive manufacturing solutions for customized healthcare applications located in Munich, Germany, was acquired by 3D Systems Corporation. Kumovis' solutions are based on their proprietary extrusion process, which was created especially for high-performance, medical-grade polymers like PEEK to be printed precisely. Furthermore, the growing acceptance of PEEK implants by medical professionals and regulatory agencies has been a major factor in the expansion of the market. North America was the dominant regional market in 2023 and accounted for the largest market share of 41.5% in the same year. The market's expansion in North America is ascribed to the existence of significant industry participants, an increase in orthopedic disorders, and government endorsements of novel products.

PEEK Implants Market Report Highlights:

• The market size was estimated at USD 906.3 million in 2023 and is expected to reach USD 964.9 Million in 2024
• The spinal implants application segment accounted for the largest revenue share of more than 36.9% in 2023
• This high share can be attributed to the increased cases of spinal disorders
• The hospitals & clinics end-use segment dominated the market with a share of around 64.1% in 2023
• Hospitals serve as primary healthcare providers, offering a wide range of medical services to individuals within the communities, which is the key factor responsible for segment growth

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. End-use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Parent market analysis (Model 2)
  • 1.7.4. Approach 2: Parent market analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market outlook
• 2.2. Segment outlook
  • 2.2.1. Application outlook
  • 2.2.2. End-use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. PEEK Implants Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising adoption for spinal implants
    • 3.2.1.2. Rise in geriatric population
    • 3.2.1.3. Increasing Increasing demand for bio-inert implants
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of skilled professionals
    • 3.2.2.2. High cost of surgeries
• 3.3. PEEK Implants Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. PEEK Implants Market: Application Estimates & Trend Analysis

• 4.1. PEEK Implants Market: Application Dashboard
• 4.2. PEEK Implants Market: Application Movement Analysis
• 4.3. PEEK Implants Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 4.4. Spinal Implants
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Orthopedic Implants
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Dental Implants
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Craniomaxillofacial Implants
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. PEEK Implants Market: End-use Estimates & Trend Analysis

• 5.1. PEEK Implants Market: End-use Dashboard
• 5.2. PEEK Implants Market: End-use Movement Analysis
• 5.3. PEEK Implants Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals and Clinics
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Ambulatory Surgical Centers
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. PEEK Implants Market: Regional Estimates & Trend Analysis by Country, Application, & End-use

• 6.1. Regional Dashboard
• 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.7. Norway
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.8. Sweden
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.9. Denmark
    • 6.4.9.1. Key country dynamics
    • 6.4.9.2. Regulatory framework/ reimbursement structure
    • 6.4.9.3. Competitive scenario
    • 6.4.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. China
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. Australia
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. South Korea
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.7. Thailand
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. Mexico
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Argentina
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. South Africa
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Kuwait
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Invibio
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Johnson & Johnson MedTech
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Evonik
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Solvay
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. In2Bones Global, Inc
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. HAPPE Spine
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. NuVasive, Inc.
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Dental Technology Services
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. 3D Systems, Inc.
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. INNOVASIS
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. SINTX Technologies, Inc.
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Product benchmarking
    • 7.3.14.4. Strategic initiatives
  • 7.3.15. Quick Implants NZ Limited.
    • 7.3.15.1. Company overview
    • 7.3.15.2. Financial performance
    • 7.3.15.3. Product benchmarking
    • 7.3.15.4. Strategic initiatives

관련자료